These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 27290799

  • 1. [Polycystic ovary syndrome: is there a rise in the prevalence?].
    Carmona-Ruiz IO, Saucedo-de la Llata E, Moraga-Sánchez MR, Romeu-Sarró A.
    Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
    [Abstract] [Full Text] [Related]

  • 2. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H.
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [Abstract] [Full Text] [Related]

  • 3. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F.
    Front Endocrinol (Lausanne); 2022 Oct; 13():825528. PubMed ID: 35299965
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
    Pehlivanov B, Orbetzova M.
    Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
    [Abstract] [Full Text] [Related]

  • 5. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO.
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, Lee J, Zane LT, Shinkai K.
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [Abstract] [Full Text] [Related]

  • 7. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC.
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [Abstract] [Full Text] [Related]

  • 8. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 9. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 10. Referral bias in female functional hyperandrogenism and polycystic ovary syndrome.
    Luque-Ramírez M, Alpañés M, Sanchón R, Fernández-Durán E, Ortiz-Flores AE, Escobar-Morreale HF.
    Eur J Endocrinol; 2015 Nov; 173(5):603-10. PubMed ID: 26243032
    [Abstract] [Full Text] [Related]

  • 11. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
    Skiba MA, Islam RM, Bell RJ, Davis SR.
    Hum Reprod Update; 2018 Nov 01; 24(6):694-709. PubMed ID: 30059968
    [Abstract] [Full Text] [Related]

  • 12. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M, Isaoglu U, Delibas IB, Kadanali S.
    J Obstet Gynaecol Res; 2011 Aug 01; 37(8):1020-6. PubMed ID: 21481088
    [Abstract] [Full Text] [Related]

  • 13. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E, Dilbaz B, Cirik DA, Ozelci R, Ozkaya E, Dilbaz S.
    J Obstet Gynaecol Res; 2016 Jul 01; 42(7):837-43. PubMed ID: 27071345
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study.
    Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F.
    Reprod Biol Endocrinol; 2011 Mar 25; 9():39. PubMed ID: 21435276
    [Abstract] [Full Text] [Related]

  • 15. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul 25; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E, Azziz R.
    Fertil Steril; 2006 Jul 25; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [Abstract] [Full Text] [Related]

  • 17. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH.
    Am J Epidemiol; 2008 Aug 01; 168(3):321-8. PubMed ID: 18550559
    [Abstract] [Full Text] [Related]

  • 18. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R, Kintziger K, Li R, Laven J, Morin-Papunen L, Merkin SS, Teede H, Yildiz BO.
    Hum Reprod; 2019 Nov 01; 34(11):2254-2265. PubMed ID: 31751476
    [Abstract] [Full Text] [Related]

  • 19. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda M, Spiazzi G, Zanolin ME, Bonora E.
    J Clin Endocrinol Metab; 2013 Apr 01; 98(4):E628-37. PubMed ID: 23476073
    [Abstract] [Full Text] [Related]

  • 20. Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes.
    Tripathy P, Sahu A, Sahu M, Nagy A.
    Eur J Obstet Gynecol Reprod Biol; 2018 May 01; 224():60-65. PubMed ID: 29550643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.